Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors

NCT00183833 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT00183833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00183833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors
Lead sponsor
University of Southern California
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2002
Completion date
August 31, 2010
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, colorectal cancer